✦ LIBER ✦

Results of phase II and phase III trials with new aromatase inhibitors

✍ Scribed by W. Jonat

Book ID: 114316809
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 864 KB
Volume: 5
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(96)90095-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quetiapine: Results of four phase II and

Quetiapine: Results of four phase II and III clinical trials

✍ D.J. King 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 458 KB

Quetiapine: results of four phase II and

Quetiapine: results of four phase II and III clinical trials

✍ DJ King 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 578 KB

Using meta-analysis of Phase II trials t

Using meta-analysis of Phase II trials to predict Phase III trial results

✍ Danielle Burke,Lucinda Billingham,Alan Girling,Richard Riley 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 123 KB

A phase I trial of CGS 16949a. A new aro

A phase I trial of CGS 16949a. A new aromatase inhibitor

✍ Allan Lipton; Harold A. Harvey; Laurence M. Demers; John R. Hanagan; Mary T. Mul 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

CGS 16949A is a new, nonsteroidal competitive inhibitor of the aromatase enzyme. In this Phase I trial, 16 heavily pretreated postmenopausal patients with metastatic breast cancer were treated with escalating doses of CGS 16949A from 0.6 to 16 mg total daily oral dose. No hematologic, biochemical, o

Treatment of advanced breast cancer with

Treatment of advanced breast cancer with the aromatase inhibitor 4-hydroxyandrostenedione: a phase II trial

✍ A. Bowman; J.F. Smyth; M.E. Stewart; A. Rodger; M. Dowsett; A.P.M. Forrest; R.C. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 526 KB

1276 POSTER Duration of onset of metasta

1276 POSTER Duration of onset of metastatic bone pain relief with ibandronate: phase III and phase II trial results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB